How many email patterns does Cyclerion use?

Cyclerion uses 12 known email patterns.

What domain does Cyclerion use for work emails?

Cyclerion uses cyclerion.com for work email addresses.

Most Common Email Formats at Cyclerion

Cyclerion's most common email format is FLast@cyclerion.com (ex. JDoe@cyclerion.com), used for 89% of cyclerion.com addresses. Cyclerion uses 4 email patterns.

@cyclerion.com

4 patterns

Format	Example	Share of cyclerion.com
FLast@cyclerion.comMost common	JDoe@cyclerion.com	89%
First.Last@cyclerion.com	John.Doe@cyclerion.com	4%
Last.First@cyclerion.com	Doe.John@cyclerion.com	4%
FirLast@cyclerion.com	JohDoe@cyclerion.com	3%

Frequently Asked Questions

What does Cyclerion do?

Cyclerion was founded in 2019 and operates in the Biotechnology Research industry, alongside similar companies like sanofi, Pfizer and AbbVie. You can visit cyclerion.com. Explore Cyclerion's company overview page for more information.

What is Cyclerion's email address format?

Cyclerion's email format typically follows the pattern of FLast@cyclerion.com; this email format is used 89% of the time. Other contacts within LeadIQ's database had email formats such as First.Last@cyclerion.com and Last.First@cyclerion.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Cyclerion have currently?

Cyclerion has approximately 10 employees as of September 2026. Key team members to contact include Senior Director, Head Of Intellectual Property: E. M., Medical Director, Clinical Development: J. S. and Sr. Director, Discovery Sciences: P. R. For more team information and contact data, explore Cyclerion's employee directory with LeadIQ.

Cyclerion Email Format

Q: What is Cyclerion's email address format?

Cyclerion's email format typically follows the pattern of ${fi}${ln}. Other email formats include ${fn}.${ln} and ${ln}.${fn}.

Biotechnology ResearchMassachusetts, United States2-10 Employees

Cyclerion is a biotechnology research company based in Cambridge, Massachusetts. Its portfolio centers on clinical-stage and research-stage assets, including praliciguat and olinciguat, with praliciguat being developed for rare kidney disease under an exclusive license to Akebia, and olinciguat targeted for cardiovascular diseases either developed in-house or out-licensed. The firm also holds equity in Tisento Therapeutics and is exploring additional activities such as collaborations, licenses, mergers, acquisitions, and targeted investments aimed at shareholder value. The company operates within the biotechnology research sector, focusing on sGC stimulators with the potential to address kidney and cardiovascular conditions, while evaluating opportunities arising from its asset portfolio and partnerships. Cyclerion is pursuing strategic moves, including a recent merger activity with Korsana Biosciences, which could affect its corporate structure and ownership dynamics moving forward.

Most Common Email Formats at Cyclerion

@cyclerion.com

Need a specific person's email?

Frequently Asked Questions

What does Cyclerion do?

What is Cyclerion's email address format?

How many employees does Cyclerion have currently?

Cyclerion Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Cyclerion

@cyclerion.com

Need a specific person's email?

Frequently Asked Questions

What does Cyclerion do?

What is Cyclerion's email address format?

How many employees does Cyclerion have currently?

Cyclerion Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.